Local Institution - 0239

Seoul, Seoul-teukbyeolsi [Seoul] 06351

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Relapsed or Refractory Multiple Myeloma

Studies at this site

• A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2) — Running, not enrolling
• A Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) — Withdrawn before enrolling